Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

Bone Marrow Transplant. 2021 Jan;56(1):289-292. doi: 10.1038/s41409-020-01001-2. Epub 2020 Jul 21.

Richard J Lin^{1

2}, Raymond E Baser³, Theresa A Elko⁴, Beatriz Korc-Grodzicki^{5

6}, Armin Shahrokni^{5

6}, Molly A Maloy⁴, James W Young^{4

5}, Roni Tamari^{4

5}, Gunjan L Shah^{4

5}, Brian C Shaffer^{4

5}, Michael Scordo^{4

5}, Craig S Sauter^{4

5}, Doris M Ponce^{4

5}, Ioannis Politikos^{4

5}, Miguel-Angel Perales^{4

5}, Esperanza B Papadopoulos^{4

5}, Boglarka Gyurkocza^{4

5}, Parastoo B Dahi^{4

5}, Christina Cho^{4

5}, Juliet N Barker^{4

5}, Ana Alarcón Tomas⁴, Nerea Castillo Flores⁴, Míriam Sanchez-Escamilla⁷, Lucrecia Yáñez San Segundo⁷, Ann A Jakubowski^{4

5}, Sergio A Giralt^{4

5}

¹ Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected].
² Department of Medicine, Weill Cornell Medical College, New York, NY, USA. [email protected].
³ Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
⁶ Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain.

No abstract available

Publication types